NasdaqGS:DFTXPharmaceuticals
Deinium Therapeutics (DFTX) Is Up 11.5% After Psychedelic Rebrand And DT120 Roadmap Reveal Has The Bull Case Changed?
Deinium Therapeutics, formerly Mind Medicine (MindMed), has rebranded, announced a forthcoming Nasdaq ticker change to DFTX, and recently launched its “Rerouting Minds” educational campaign to explain the scientific and therapeutic potential of pharmaceutical LSD in mental health care.
Alongside this, the company is outlining an ambitious 2026 roadmap for DT120 ODT in generalized anxiety disorder and major depressive disorder, plus early-stage work in autism spectrum disorder, signaling a...